<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-92520</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Rituximab in rheumatoid arthritis-associated peripheral ulcerative keratitis</dc:title>
<dc:description xml:lang="en">Clinical case: We report two cases of patients affected by longstanding rheumatoid arthritiswho developed a severe form of peripheral ulcerative keratitis (PUK). Neither of them hadan optimal biological and clinical control of their systemic illness despite being treated withseveral disease-modifying antirheumatic drugs (DMARDs) and biologic therapy. High-dosesystemic corticosteroidswere given to treat the PUK without any success. Rituximab resultedin a favourable response with resolution of the corneal lesions and optimal control of theirsystemic illness.Discussion: Rituximab may be an additional tool to arrest progressive rheumatoid arthritisassociatedPUK that is refractory to other drug(AU)</dc:description>
<dc:creator>Martínez-Costa, L</dc:creator>
<dc:creator>Beltrán, E</dc:creator>
<dc:creator>Albert, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: : Se presentan dos pacientes diagnosticadas de artritis reumatoide de largaevolución que desarrollaron una queratitis ulcerativa periférica (QUP) grave. Habían sidotratadas previamente con fármacos modificadores de la enfermedad (FAME) y terapia biológica(TB) sin alcanzar un control clínico-biológico óptimo de su enfermedad. Se trataroninicialmente con corticoides sistémicos a dosis altas sin éxito. Rituximab indujo la regresiónde las lesiones corneales y el control de su artritis reumatoidea.Discusión: Rituximab puede ser una alternativa para detener la progresión de la QUP asociadaa artritis reumatoide refractaria a otros fármacos(AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;86(4): 118-120, abr. 2011. ilus</dc:source>
<dc:identifier>ibc-92520</dc:identifier>
<dc:title xml:lang="es">Rituximab en queratitis ulcerativa periférica asociada a artritis reumatoide</dc:title>
<dc:subject>^d29591^s22006</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d27978^s22057</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d27978^s22011</dc:subject>
<dc:subject>^d27978^s22016</dc:subject>
<dc:subject>^d27978^s22027</dc:subject>
<dc:subject>^d920^s22073</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d32850</dc:subject>
<dc:subject>^d32355^s22073</dc:subject>
<dc:subject>^d1178^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201104</dc:date>
</metadata>
</record>
</ibecs-document>
